TY - JOUR
T1 - Addressing multimorbidity in evidence integration and synthesis
AU - Trikalinos, Thomas A.
AU - Segal, Jodi B.
AU - Boyd, Cynthia M.
N1 - Funding Information:
Acknowledgements: This project was funded by grant R21 HS18597 and R21 HS017653 from the Agency for Healthcare Research and Quality. Dr. Boyd's effort was funded by the Paul Beeson Career Development Award Program (National Institute on Aging 1K23AG032910, AFAR, The John A. Hartford Foundation, The Atlantic Philanthropies, The Starr Foundation and an anonymous donor).
PY - 2014/4
Y1 - 2014/4
N2 - To minimize bias, clinical practice guidelines (CPG) for managing patients with multiple conditions should be informed by well-planned syntheses of the totality of the relevant evidence by means of systematic reviews and meta-analyses. However, deficiencies along the entire evidentiary pathway hinder the development of evidence-based CPGs. Published reports of trials and observational studies often do not provide usable data on treatment effect heterogeneity, perhaps because their design, analysis and presentation is seldom geared towards informing on how multimorbidity modifies the effect of treatments. Systematic reviews and meta-analyses inherit all the limitations of their building blocks and introduce additional of their own, including selection biases at the level of the included studies, ecological biases, and analytical challenges. To generate recommendations to help negotiate some of the challenges in synthesizing the primary literature, so that the results of the evidence synthesis is applicable to the care of those with multiple conditions. Informal group process. We have built upon established general guidance, and provide additional recommendations specific to systematic reviews that could improve the CPGs for multimorbid patients. We suggest that following the additional recommendations is good practice, but acknowledge that not all proposed recommendations are of equal importance, validity and feasibility, and that further work is needed to test and refine the recommendations.
AB - To minimize bias, clinical practice guidelines (CPG) for managing patients with multiple conditions should be informed by well-planned syntheses of the totality of the relevant evidence by means of systematic reviews and meta-analyses. However, deficiencies along the entire evidentiary pathway hinder the development of evidence-based CPGs. Published reports of trials and observational studies often do not provide usable data on treatment effect heterogeneity, perhaps because their design, analysis and presentation is seldom geared towards informing on how multimorbidity modifies the effect of treatments. Systematic reviews and meta-analyses inherit all the limitations of their building blocks and introduce additional of their own, including selection biases at the level of the included studies, ecological biases, and analytical challenges. To generate recommendations to help negotiate some of the challenges in synthesizing the primary literature, so that the results of the evidence synthesis is applicable to the care of those with multiple conditions. Informal group process. We have built upon established general guidance, and provide additional recommendations specific to systematic reviews that could improve the CPGs for multimorbid patients. We suggest that following the additional recommendations is good practice, but acknowledge that not all proposed recommendations are of equal importance, validity and feasibility, and that further work is needed to test and refine the recommendations.
KW - clinical practice guidelines
KW - comorbidity
KW - consensus
KW - systematic review methods
UR - http://www.scopus.com/inward/record.url?scp=84898596728&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898596728&partnerID=8YFLogxK
U2 - 10.1007/s11606-013-2661-4
DO - 10.1007/s11606-013-2661-4
M3 - Article
C2 - 24442334
AN - SCOPUS:84898596728
SN - 0884-8734
VL - 29
SP - 661
EP - 669
JO - Journal of general internal medicine
JF - Journal of general internal medicine
IS - 4
ER -